Decreased relapse risk after allogeneic hematopoietic stem cell transplantation (HSCT) in myelofibrosis with splenomegaly

被引：0
|
作者：
Ditschkowski, M. [1 ]
Steckel, N. K. [1 ]
Trenschel, R. [1 ]
Gromke, T. [1 ]
Beelen, D. W. [1 ]
机构：
[1] Univ Klinikum Essen, Klin Knochenmarktransplantat, Essen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V707
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [41] Risk factors of extramedullary relapse after allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemia
    祖璎玲
    ChinaMedicalAbstracts(InternalMedicine), 2021, 38 (02) : 116 - 117
  • [42] Disruption of the oral microbiota is associated with a higher risk of relapse after allogeneic hematopoietic stem cell transplantation
    Vinícius Campos de Molla
    Vitor Heidrich
    Julia Stephanie Bruno
    Franciele Hinterholz Knebel
    Wanessa Miranda-Silva
    Paula Fontes Asprino
    Luciana Tucunduva
    Vanderson Rocha
    Yana Novis
    Anamaria Aranha Camargo
    Eduardo Rodrigues Fregnani
    Celso Arrais-Rodrigues
    Scientific Reports, 11
  • [43] Disruption of the oral microbiota is associated with a higher risk of relapse after allogeneic hematopoietic stem cell transplantation
    de Molla, Vinicius Campos
    Heidrich, Vitor
    Bruno, Julia Stephanie
    Knebel, Franciele Hinterholz
    Miranda-Silva, Wanessa
    Asprino, Paula Fontes
    Tucunduva, Luciana
    Rocha, Vanderson
    Novis, Yana
    Camargo, Anamaria Aranha
    Fregnani, Eduardo Rodrigues
    Arrais-Rodrigues, Celso
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Relapse after allogeneic stem cell transplantation
    Barrett, A. John
    Battiwalla, Minoo
    EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (04) : 429 - 441
  • [45] Unrelated hematopoietic stem cell transplantation (HSCT) for myelofibrosis with myeloid metaplasia.
    Koldehoff, M
    Basara, N
    Kiehl, MM
    Fauser, AA
    BLOOD, 2001, 98 (11) : 385B - 385B
  • [46] HEMATOPOIETIC CELL TRANSPLANTATION CO-MORBIDITY INDEX (HCT-CI) TO PREDICT NON RELAPSE MORTALITY (NRM) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
    Colella, M. P.
    Miranda, E. C. M.
    Aranba, F. J. P.
    Fernandes-Junior, V. C. A.
    Medina, S. M.
    de Souza, C. A.
    Vigorito, A. C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S330 - S330
  • [47] Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) as a Platform for Cancer Immunotherapy
    Fry, Terry
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (04) : 244 - 244
  • [48] Outcomes of Second Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Children
    Schechter, Tal
    Avila, Laura
    Dupuis, L. Lee
    Pollock-BarZiv, Stacey
    Gassas, Adam
    Finkelstein, Yaron
    Armstrong, Christine
    Doyle, John J.
    BLOOD, 2008, 112 (11) : 1119 - 1119
  • [49] NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
    Porter, David L.
    Alyea, Edwin P.
    Antin, Joseph H.
    DeLima, Marcos
    Estey, Eli
    Falkenburg, J. H. Frederik
    Hardy, Nancy
    Kroeger, Nicolaus
    Leis, Jose
    Levine, John
    Maloney, David G.
    Peggs, Karl
    Rowe, Jacob M.
    Wayne, Alan S.
    Giralt, Sergio
    Bishop, Michael R.
    van Besien, Koen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (11) : 1467 - 1503
  • [50] Risk Factors For Relapse In Children Undergoing Preemptive Immunomodulatory Therapy After Allogeneic Hematopoietic Stem Cell (HSCT) For Acute Leukemia
    Ouachee-Chardin, Marie
    Dvorak, Christopher C.
    Wahlstrom, Justin
    Cowan, Morton Jerome
    Facchino, Janelle
    Horn, Biljana N.
    BLOOD, 2013, 122 (21)
12345